Northrop beats big, but the stock still dips

Big quarter, weird reaction

Northrop Grumman came out swinging in Q2: adjusted EPS of $7.68 beat the $6.82 Street estimate, and revenue of $10.87 billion also edged past expectations. On top of that, the company piled up $20 billion in net awards, pushing backlog to a fresh record of $104.7 billion.

The order book is doing heavy lifting

That backlog wasn’t built on vibes. Big-ticket wins included $7.6 billion for Sentinel, $4.3 billion for restricted programs, $1.0 billion for F-35 work, $0.8 billion for Glide Phase Interceptor, and $0.7 billion for Multi-role Electronically Scanned Array programs. Translation: customers are still signing checks, and they’re not exactly writing tiny ones.

Management’s tone: pretty upbeat

CEO Kathy Warden said the record backlog was driven by robust global demand for Northrop’s products, and the company responded by raising full-year adjusted EPS guidance to $28.60-$29.10 from $27.40-$27.90. Revenue guidance also moved up to $43.75 billion-$44.25 billion from $43.50 billion-$44.00 billion.

So why is the stock down?

Because markets are dramatic little creatures. Even with a beat-and-raise quarter, Northrop shares fell 4.34% to $501.21 at the time of publication. Investors may be taking profits, or they may simply be deciding that a great report is not the same thing as a great excuse to bid the stock higher.

Big picture: Northrop looks like it has demand, visibility, and momentum. The stock, meanwhile, is acting like it just found out “strong quarter” is not always a synonym for “up only.”